Biological therapy for moderate-to-severe psoriasis is highly effective but cost-intensive. This
systematic review aimed at analyzing evidence on the cost-effectiveness of biological …

Background Many national guidelines at the European level recommend first‐line therapy
based on the anti‐TNF‐alpha adalimumab for treatment of psoriasis and psoriatic arthritis …

In the course of the chronic skin disease psoriasis, where a variety of treatment interventions
is available, a strong growth of health economic studies comparing treatment costs and …

Objective In Malaysia, there is now a dearth of recommendations pertaining to the priority of
biologic treatments for the effective management of psoriasis, given the multitude of …

Background: There is limited evidence detailing the cost-effectiveness of psoriasis
treatments in the Asian region. Therefore, this study is aimed to evaluate the cost …

RESUMO INTRODUÇÃO: A Psoríase é uma doença inflamatória crônica que acomete
principalmente a pele e as articulações. Em pacientes com psoríase moderada ou grave …

Psoriasis is a chronic, recurrent, autoimmune skin disease. In Croatia, around 80,000
people have some form of psoriasis, and 20% have moderate or severe psoriasis. The total …

The article presented examines the usage, payment, market share and impact on the budget
of the National Health Insurance Fund (NHIF),(the perspective of the payer) as well as …

РЕЗЮМЕ В статията са разгледани данните за използването, заплащането, пазарния
дял и въздействието върху бюджета на НЗОК (перспективата на платеца) на …

The aim of the study is to analyze the published data from health technology assessments
for the treatment of plaque psoriasis (PS) conducted in other countries to model the costs …